1e
19
1
49
2
2
18
1b
1d
18
2b
52
1d
2 29
1d
25
Laszlo Gyulai
78
52
Emeritus Associate Professor CE of Psychiatry
7
61
Department: Psychiatry
4
1
b
1d
46
Contact information
30
4
3
3
3
2
4
b
1f
30
HUP
16 3400 SPRUCE ST.
27 4283
Philadelphia, PA 19104
26
16 3400 SPRUCE ST.
27 4283
Philadelphia, PA 19104
2c
Office: 2158984387
30
93
30
Email:
gyulai@mail.med.upenn.edu
12
gyulai@mail.med.upenn.edu
13
Education:
21 9 M.D. 26 (Graduated Summa Cum Laude) c
3f Semmelweis Medical University, Hungary, 1973.
21 8 N/A 30 (Philosophy - Post Graduate Training) c
40 Eotvos L. University, Budapest, Hungary, 1980.
c
3
3
3
3
8a
Permanent link21 9 M.D. 26 (Graduated Summa Cum Laude) c
3f Semmelweis Medical University, Hungary, 1973.
21 8 N/A 30 (Philosophy - Post Graduate Training) c
40 Eotvos L. University, Budapest, Hungary, 1980.
c
2 29
21
1e
1d
24
2b
29
27
23
c8 Gyulai L. Bowden CL. McElroy SL. Calabrese JR. Petty F. Swann AC. Chou JC. Wassef A. Risch CS. Hirschfeld RM. Nemeroff CB. Keck PE Jr. Evans DL. Wozniak PJ. 55 : Maintenance efficacy of divalproex in the prevention of bipolar depression 42 Neuropsychopharmacology 28: 374-82, 2003.
11c Gyulai, L., Bauer, M., Garcia-Espana, F., Hierholzer, J., Baumgartner, A., Whybrow, P.C. : Supressive doses of thyroxine and bone mineral density in pre- and postmenopasual women with affective disorder. J. of Affective Disorders 27 66: 185-191, 2001.
130 Nemeroff, C., Evans, D., Gyulai, L., Sachs, G., Bowden, C., Young, M., Pitts, C., Oaks, R., Gergel, I.: A Double-Blind, Placebo-Controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. American Journal of Psychiatry 28 158: 906-912, 2001.
c5 Cory Newman, Noreen Reilly-Harrington, Laszlo Gyulai, Aaron T. Beck: Cognitive Therapy of Bipolar Disorder. APA Press, 2001.
183 Bowden, C. H., Calabrese, J., McElroy, S., Gyulai, L., Wassef, A., Petty, F., Pope, HG., Chou C-Y., Keck, P., Rhodes, L., Swann, A., Hirschfeld, RM., Wozniak, P.: Randomized, Placebo-Controlled Trial of Divalproex Versus Lithium in Maintenance Therapy of Bipolar Disorder. Arch. Gen. Psychiatry 57: 481-489, 2000.
63 Sachs GS. Printz DJ. Kahn DA. Carpenter D. Docherty JP. 5f : The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000 5e Postgraduate Medicine Page: 1-104, 2000 Notes: Contributor as Expert
a4 Bauer, M, Berghoefer, A, Baumgartner, A, Gyulai, L, Whybrow, P.C.: T4 Enhancement in Bipolar and Unipolar Illness 3f Neuropsychopharmacology 23: S68, 2000.
10d Hahn, C., Pawlyk A.C., Whybrow, P.C., Gyulai, L.,Tejani-Butt, S.M.: Lithium Administration Affects Gene Expression of Thyroid Hormone Receptors in Rat Brain. Life Sciences 64(20): 1793-1802, 1999.
ce Rapaport, M.H., Gyulai,L. Whybrow, P.C.: Immune Parameters in Rapid Cycling Bipolar patients Before and After Lithium Treatment. J. Psychiatry Research 27 33: 335-340, 1999.
2c
7
1d
1f
Selected Publications
11c Gyulai, L., Bauer M., Bauer,M.S., Espana-Garcia, F, Whybrow, P.C.: Lithium challenge to the thyroid axis in rapid cycling bipolar affective disorder and healthy controls. Biological Psychiatry 53: 899-905, 2003.c8 Gyulai L. Bowden CL. McElroy SL. Calabrese JR. Petty F. Swann AC. Chou JC. Wassef A. Risch CS. Hirschfeld RM. Nemeroff CB. Keck PE Jr. Evans DL. Wozniak PJ. 55 : Maintenance efficacy of divalproex in the prevention of bipolar depression 42 Neuropsychopharmacology 28: 374-82, 2003.
11c Gyulai, L., Bauer, M., Garcia-Espana, F., Hierholzer, J., Baumgartner, A., Whybrow, P.C. : Supressive doses of thyroxine and bone mineral density in pre- and postmenopasual women with affective disorder. J. of Affective Disorders 27 66: 185-191, 2001.
130 Nemeroff, C., Evans, D., Gyulai, L., Sachs, G., Bowden, C., Young, M., Pitts, C., Oaks, R., Gergel, I.: A Double-Blind, Placebo-Controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. American Journal of Psychiatry 28 158: 906-912, 2001.
c5 Cory Newman, Noreen Reilly-Harrington, Laszlo Gyulai, Aaron T. Beck: Cognitive Therapy of Bipolar Disorder. APA Press, 2001.
183 Bowden, C. H., Calabrese, J., McElroy, S., Gyulai, L., Wassef, A., Petty, F., Pope, HG., Chou C-Y., Keck, P., Rhodes, L., Swann, A., Hirschfeld, RM., Wozniak, P.: Randomized, Placebo-Controlled Trial of Divalproex Versus Lithium in Maintenance Therapy of Bipolar Disorder. Arch. Gen. Psychiatry 57: 481-489, 2000.
63 Sachs GS. Printz DJ. Kahn DA. Carpenter D. Docherty JP. 5f : The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000 5e Postgraduate Medicine Page: 1-104, 2000 Notes: Contributor as Expert
a4 Bauer, M, Berghoefer, A, Baumgartner, A, Gyulai, L, Whybrow, P.C.: T4 Enhancement in Bipolar and Unipolar Illness 3f Neuropsychopharmacology 23: S68, 2000.
10d Hahn, C., Pawlyk A.C., Whybrow, P.C., Gyulai, L.,Tejani-Butt, S.M.: Lithium Administration Affects Gene Expression of Thyroid Hormone Receptors in Rat Brain. Life Sciences 64(20): 1793-1802, 1999.
ce Rapaport, M.H., Gyulai,L. Whybrow, P.C.: Immune Parameters in Rapid Cycling Bipolar patients Before and After Lithium Treatment. J. Psychiatry Research 27 33: 335-340, 1999.
2c